Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2015-06-12 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PREAUX (76160), Seine-Maritime
PHARMACIE DE PREAUX : revenue, balance sheet and financial ratios
PHARMACIE DE PREAUX is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PREAUX (76160),
this company of category PME
shows in 2024 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE PREAUX (SIREN 811974542)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 258 516 €
1 204 182 €
1 219 941 €
1 106 856 €
979 044 €
N/C
N/C
N/C
N/C
Net income
47 451 €
35 485 €
37 951 €
57 282 €
58 288 €
31 939 €
66 725 €
69 136 €
85 262 €
-32 553 €
EBITDA
N/C
45 403 €
45 786 €
69 957 €
74 738 €
43 130 €
N/C
N/C
N/C
N/C
Net margin
N/C
2.8%
3.2%
4.7%
5.3%
3.3%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE PREAUX generates positive net income of 47 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
47 451 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 69%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
68.952%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
49.666%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
1235.053
462.618
283.612
194.359
181.527
146.038
126.04
102.319
85.55
68.952
Financial autonomy
6.707
15.737
22.51
30.506
30.583
34.884
37.672
42.063
44.661
49.666
Repayment capacity
None
None
None
None
19.123
9.705
9.3
11.691
10.266
None
Cash flow / Revenue
None%
None%
None%
None%
3.011%
5.014%
4.289%
3.082%
3.01%
None%
Sector positioning
Debt ratio
68.952025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average
In 2025, the debt ratio of PHARMACIE DE PREAUX (68.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
49.67%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average
In 2025, the financial autonomy of PHARMACIE DE PREAUX (49.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
10.27 years2024
2023
2024
Q1: 0.52 years
Med: 3.18 years
Q3: 7.6 years
Watch
In 2024, the repayment capacity of PHARMACIE DE PREAUX (10.27) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 175.39. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
175.387
Liquidity indicators evolution PHARMACIE DE PREAUX
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
166.18
191.194
180.254
220.618
216.015
232.474
208.53
194.779
172.091
175.387
Interest coverage
None
None
None
None
7.691
2.739
2.502
5.22
2.526
None
Sector positioning
Liquidity ratio
175.392025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Average-5 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE PREAUX (175.39) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
2.53x2024
2023
2024
Q1: 0.0x
Med: 2.34x
Q3: 7.73x
Good-16 pts over 2 years
In 2024, the interest coverage of PHARMACIE DE PREAUX (2.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE PREAUX
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
147 562 €
148 485 €
112 308 €
134 062 €
147 272 €
0 €
Inventory turnover (days)
0
0
0
0
36
38
33
37
36
0
Customer payment term (days)
0
0
0
0
6
9
5
3
5
0
Supplier payment term (days)
0
0
0
0
43
46
41
45
54
0
Positioning of PHARMACIE DE PREAUX in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE PREAUX is estimated at
753 764 €
(range 511 508€ - 1 182 760€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
511k€753k€1182k€
753 764 €Range: 511 508€ - 1 182 760€
NAF 5 année 2025
Valuation method used
Net Income Multiple
47 451 €
×
15.9x
=753 765 €
Range: 511 508€ - 1 182 761€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE PREAUX with other companies in the same sector:
Frequently asked questions about PHARMACIE DE PREAUX
What is the revenue of PHARMACIE DE PREAUX ?
The revenue of PHARMACIE DE PREAUX in 2024 is 1.3 M€.
Is PHARMACIE DE PREAUX profitable?
Yes, PHARMACIE DE PREAUX generated a net profit of 47 k€ in 2025.
Where is the headquarters of PHARMACIE DE PREAUX ?
The headquarters of PHARMACIE DE PREAUX is located in PREAUX (76160), in the department Seine-Maritime.
Where to find the tax return of PHARMACIE DE PREAUX ?
The tax return of PHARMACIE DE PREAUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE PREAUX operate?
PHARMACIE DE PREAUX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart